Katalog der Deutschen Nationalbibliothek

Gesamter Bestand

Musikarchiv

Exilsammlungen

Buchmuseum

Suchformular zurücksetzen

Expertensuche ?

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

Die Lesesäle für Geisteswissenschaften, Naturwissenschaften, der Alte Lesesaal Technik und der Anne-Frank-Shoah-Lesesaal in Leipzig schließen am 04.02.2026 wegen einer Veranstaltung bereits um 15 Uhr. Die weiteren Lesesäle sowie die Servicetheke sind zu den regulären Zeiten geöffnet. //
The humanities reading room, the natural science reading room, the old technology reading room and the reading room of the Anne-Frank-Shoah-Library will close at 15:00 on 4 February 2026 due to an event. The other reading rooms and the service desk will be open during regular hours.

Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

8971 - 8980 von 9948

	8971	Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study Enthalten in Neurology and Therapy Bd. 11, 2.7.2022, Nr. 3, date:9.2022: 1353-1374
	8972	Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials Enthalten in Arthritis Research & Therapy Bd. 15, 24.9.2013, Nr. 5, date:10.2013: 1-10
	8973	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults Enthalten in Infectious diseases and therapy Bd. 12, 25.1.2023, Nr. 2, date:2.2023: 663-675
	8974	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Firsekibart, an Anti-interleukin-1β Monoclonal Antibody, in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study Enthalten in Advances in therapy Bd. 42, 25.7.2025, Nr. 9, date:9.2025: 4611-4625
	8975	Safety, tolerability, pharmacokinetics, and pharmacodynamics of TG103 injection in participants who are overweight or obese: a randomized, double-blind, placebo-controlled, multiple-dose phase 1b study Enthalten in BMC medicine Bd. 22, 29.5.2024, Nr. 1, date:12.2024: 1-12
	8976	Salbutamol for analgesia in renal colic: study protocol for a prospective, randomised, placebo-controlled phase II trial (SARC) Enthalten in Trials Bd. 23, 25.4.2022, Nr. 1, date:12.2022: 1-15
	8977	SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study Enthalten in Supportive care in cancer Bd. 21, 4.9.2012, Nr. 3, date:3.2013: 827-834
	8978	Sandborn W, Feagan BG, Gasink C, et al (2016) A phase 3 randomized, multicenter, double-blind, placebo-controlled study of ustekinumab maintenance therapy in moderate–severe Crohn’s disease patients: Results from IM-UNITI. Gastroenterology AGA abstract 768 Enthalten in Côlon & rectum Bd. 10, 22.9.2016, Nr. 4, date:11.2016: 260-263
	8979	Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan Enthalten in Arthritis Research & Therapy Bd. 21, 20.3.2019, Nr. 1, date:12.2019: 1-14
	8980	SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure Enthalten in Trials Bd. 25, 18.5.2024, Nr. 1, date:12.2024: 1-19